Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 11 - 03 tags : Treatment save search
Pediatric Health Market Research Report by Type, Therapeutics, Treatment, Treatment Type, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-03 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.02%
H: 0.43%
C: 0.43%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -1.02%
H: 2.67%
C: 0.18%
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 2.28%
H: 0.0%
C: 0.0%
VTRS | News A | $11.36 0.98% 0.97% 4.7M
|
Health Technology
|
| O: 0.83%
H: 1.33%
C: -0.51%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 1.13%
H: 0.63%
C: 0.53%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.97%
H: 0.18%
C: -2.13%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: 0.42%
H: 0.59%
C: -0.04%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: 1.43%
H: 0.41%
C: 0.25%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 2.05%
H: 0.0%
C: 0.0%
GILD | $67.03 0.12% 0.12% 5.2M
|
Health Technology
|
| O: -0.4%
H: 2.75%
C: 1.52%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: 0.72%
H: 1.29%
C: 1.04%
covid-19 treatment research global report impact health market
Pooled Data from the Pivotal Phase 3 VANISH Program Published in the Journal of Women’s Health Demonstrate Significant Efficacy of Ibrexafungerp Over Placebo for Treatment of Vaginal Yeast Infection
Published: 2022-11-03 (Crawled : 13:20) - biospace.com/
SCYX | $1.53 6.25% 5.88% 150K
|
Health Technology
|
| O: 0.0%
H: 5.0%
C: 2.73%
treatment health program infection
BrainsWay Announces Private Insurance Coverage from Premera Blue Cross for the Treatment of OCD Utilizing Deep TMS™
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
BWAY | $4.89 2.95% 2.86% 28K
|
Health Technology
|
| O: -1.75%
H: 2.94%
C: 2.94%
treatment insurance blue
Centessa Pharmaceuticals to Present Additional 18-Months of Continued Treatment Data with SerpinPC from Open-Label Extension of Phase 2a Study at 64th ASH Annual Meeting
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
CNTA | News | $9.42 -5.8% -6.16% 200K
|
Manufacturing
|
| O: -0.97%
H: 0.0%
C: -2.7%
treatment pharmaceuticals extension study phase 2b
Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem™, a Novel Cell Therapy for the Treatment of Type 1 Diabetes
Published: 2022-11-03 (Crawled : 12:20) - biospace.com/
CELZ | $4.8301 0.21% 9.6K
|
|
| O: 19.85%
H: 41.67%
C: 4.17%
treatment fda clearance drug application technology diabetes therapy
REGENXBIO Presents Positive Interim Data from and the Expansion of Phase II ALTITUDE® Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery
Published: 2022-11-03 (Crawled : 12:00) - biospace.com/
RGNX | $15.885 1.57% 1.54% 360K
|
Health Technology
|
| O: -3.01%
H: 0.77%
C: -10.46%
CLSD | News P | $1.36 -3.55% -3.68% 230K
|
Health Technology
|
| O: 0.74%
H: 11.76%
C: 7.35%
rgx-314 altitude treatment expansion trial positive diabetic
Clinical Evaluation of Aptinyx's NYX-783 for Treatment of Opioid Use Disorder to Be Funded by $5.6 Million NIH Grant
Published: 2022-11-03 (Crawled : 12:00) - biospace.com/
APTX | $0.061 21.31% 7.8M
|
Health Services
|
| O: -7.89%
H: 0.0%
C: 0.0%
nyx-783 treatment opioid grant
Atea Pharmaceuticals Presents Favorable AT-752 Phase 1 Data for Treatment of Dengue Fever at American Society of Tropical Medicine & Hygiene 2022 Annual Meeting
Published: 2022-11-03 (Crawled : 11:00) - ir.ateapharma.com
AVIR | $3.725 1.5% 1.48% 180K
|
Health Technology
|
| O: 0.85%
H: 3.19%
C: 1.68%
at-752 treatment pharmaceuticals meeting dengue phase 1
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.